1 Market Overview

1.1 Product Overview and Scope of Bio Similars/Subsequent Entry Biologic

1.2 Classification of Bio Similars/Subsequent Entry Biologic by Type

1.2.1 Overview: Global Bio Similars/Subsequent Entry Biologic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type in 2020

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Other

1.3 Global Bio Similars/Subsequent Entry Biologic Market by Application

1.3.1 Overview: Global Bio Similars/Subsequent Entry Biologic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Bio Similars/Subsequent Entry Biologic Market Size & Forecast

1.5 Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Region

1.5.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Bio Similars/Subsequent Entry Biologic Market Size by Region, (2016-2021)

1.5.3 North America Bio Similars/Subsequent Entry Biologic Market Size and Prospect (2016-2026)

1.5.4 Europe Bio Similars/Subsequent Entry Biologic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size and Prospect (2016-2026)

1.5.6 South America Bio Similars/Subsequent Entry Biologic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Bio Similars/Subsequent Entry Biologic Market Drivers

1.6.2 Bio Similars/Subsequent Entry Biologic Market Restraints

1.6.3 Bio Similars/Subsequent Entry Biologic Trends Analysis

2 Company Profiles

2.1 Sun Pharma

2.1.1 Sun Pharma Details

2.1.2 Sun Pharma Major Business

2.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Product and Solutions

2.1.4 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Sun Pharma Recent Developments and Future Plans

2.2 Synthon Pharmaceuticals

2.2.1 Synthon Pharmaceuticals Details

2.2.2 Synthon Pharmaceuticals Major Business

2.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product and Solutions

2.2.4 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Synthon Pharmaceuticals Recent Developments and Future Plans

2.3 Teva Pharmaceutical Industries

2.3.1 Teva Pharmaceutical Industries Details

2.3.2 Teva Pharmaceutical Industries Major Business

2.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product and Solutions

2.3.4 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans

2.4 LG Life Sciences

2.4.1 LG Life Sciences Details

2.4.2 LG Life Sciences Major Business

2.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Product and Solutions

2.4.4 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 LG Life Sciences Recent Developments and Future Plans

2.5 Celltrion Biocon

2.5.1 Celltrion Biocon Details

2.5.2 Celltrion Biocon Major Business

2.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

2.5.4 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Celltrion Biocon Recent Developments and Future Plans

2.6 Hospira

2.6.1 Hospira Details

2.6.2 Hospira Major Business

2.6.3 Hospira Bio Similars/Subsequent Entry Biologic Product and Solutions

2.6.4 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Hospira Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Bio Similars/Subsequent Entry Biologic Product and Solutions

2.7.4 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck Recent Developments and Future Plans

2.8 Biogen idec

2.8.1 Biogen idec Details

2.8.2 Biogen idec Major Business

2.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Product and Solutions

2.8.4 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Biogen idec Recent Developments and Future Plans

2.9 Genentech (Roche)

2.9.1 Genentech (Roche) Details

2.9.2 Genentech (Roche) Major Business

2.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product and Solutions

2.9.4 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Genentech (Roche) Recent Developments and Future Plans

2.10 Pfizer

2.10.1 Pfizer Details

2.10.2 Pfizer Major Business

2.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Product and Solutions

2.10.4 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Pfizer Recent Developments and Future Plans

2.11 Celltrion

2.11.1 Celltrion Details

2.11.2 Celltrion Major Business

2.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Product and Solutions

2.11.4 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Celltrion Recent Developments and Future Plans

2.12 Biocon

2.12.1 Biocon Details

2.12.2 Biocon Major Business

2.12.3 Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

2.12.4 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Biocon Recent Developments and Future Plans

2.13 Amgen

2.13.1 Amgen Details

2.13.2 Amgen Major Business

2.13.3 Amgen Bio Similars/Subsequent Entry Biologic Product and Solutions

2.13.4 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Amgen Recent Developments and Future Plans

2.14 Samsung Biologics

2.14.1 Samsung Biologics Details

2.14.2 Samsung Biologics Major Business

2.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Product and Solutions

2.14.4 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Samsung Biologics Recent Developments and Future Plans

2.15 Mylan

2.15.1 Mylan Details

2.15.2 Mylan Major Business

2.15.3 Mylan Bio Similars/Subsequent Entry Biologic Product and Solutions

2.15.4 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Mylan Recent Developments and Future Plans

2.16 Dr. Reddy's Laboratories

2.16.1 Dr. Reddy's Laboratories Details

2.16.2 Dr. Reddy's Laboratories Major Business

2.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product and Solutions

2.16.4 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Dr. Reddy's Laboratories Recent Developments and Future Plans

2.17 Stada Arzneimittel AG

2.17.1 Stada Arzneimittel AG Details

2.17.2 Stada Arzneimittel AG Major Business

2.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product and Solutions

2.17.4 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Stada Arzneimittel AG Recent Developments and Future Plans

2.18 AbbVie

2.18.1 AbbVie Details

2.18.2 AbbVie Major Business

2.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Product and Solutions

2.18.4 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 AbbVie Recent Developments and Future Plans

2.19 Sanofi-Aventis

2.19.1 Sanofi-Aventis Details

2.19.2 Sanofi-Aventis Major Business

2.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product and Solutions

2.19.4 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Sanofi-Aventis Recent Developments and Future Plans

2.20 Johnson & Johnson

2.20.1 Johnson & Johnson Details

2.20.2 Johnson & Johnson Major Business

2.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product and Solutions

2.20.4 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Johnson & Johnson Recent Developments and Future Plans

2.21 Novo Nordisk

2.21.1 Novo Nordisk Details

2.21.2 Novo Nordisk Major Business

2.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Product and Solutions

2.21.4 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Novo Nordisk Recent Developments and Future Plans

2.22 Eli Lilly

2.22.1 Eli Lilly Details

2.22.2 Eli Lilly Major Business

2.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Product and Solutions

2.22.4 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Eli Lilly Recent Developments and Future Plans

2.23 Novartis

2.23.1 Novartis Details

2.23.2 Novartis Major Business

2.23.3 Novartis Bio Similars/Subsequent Entry Biologic Product and Solutions

2.23.4 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 Novartis Recent Developments and Future Plans

2.24 3sbio

2.24.1 3sbio Details

2.24.2 3sbio Major Business

2.24.3 3sbio Bio Similars/Subsequent Entry Biologic Product and Solutions

2.24.4 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 3sbio Recent Developments and Future Plans

2.25 Biotech

2.25.1 Biotech Details

2.25.2 Biotech Major Business

2.25.3 Biotech Bio Similars/Subsequent Entry Biologic Product and Solutions

2.25.4 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Biotech Recent Developments and Future Plans

2.26 Gelgen

2.26.1 Gelgen Details

2.26.2 Gelgen Major Business

2.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Product and Solutions

2.26.4 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Gelgen Recent Developments and Future Plans

2.27 Innovent

2.27.1 Innovent Details

2.27.2 Innovent Major Business

2.27.3 Innovent Bio Similars/Subsequent Entry Biologic Product and Solutions

2.27.4 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Innovent Recent Developments and Future Plans

2.28 Dong Bao

2.28.1 Dong Bao Details

2.28.2 Dong Bao Major Business

2.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Product and Solutions

2.28.4 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Dong Bao Recent Developments and Future Plans

2.29 Ganlee

2.29.1 Ganlee Details

2.29.2 Ganlee Major Business

2.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Product and Solutions

2.29.4 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2019-2021)

2.29.5 Ganlee Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Bio Similars/Subsequent Entry Biologic Players Market Share

3.2.2 Top 10 Bio Similars/Subsequent Entry Biologic Players Market Share

3.2.3 Market Competition Trend

3.3 Bio Similars/Subsequent Entry Biologic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Type (2016-2021)

4.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2016-2021)

5.2 Bio Similars/Subsequent Entry Biologic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2026)

6.2 North America Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2026)

6.3 North America Bio Similars/Subsequent Entry Biologic Market Size by Country

6.3.1 North America Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2026)

6.3.2 United States Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

6.3.3 Canada Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

6.3.4 Mexico Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2026)

7.2 Europe Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2026)

7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Country

7.3.1 Europe Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2026)

7.3.2 Germany Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

7.3.3 France Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

7.3.5 Russia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

7.3.6 Italy Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2026)

8.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2026)

8.3 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Region

8.3.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Region (2016-2026)

8.3.2 China Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8.3.3 Japan Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8.3.4 South Korea Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8.3.5 India Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

8.3.7 Australia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2026)

9.2 South America Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2026)

9.3 South America Bio Similars/Subsequent Entry Biologic Market Size by Country

9.3.1 South America Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2026)

9.3.2 Brazil Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

9.3.3 Argentina Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2026)

10.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2026)

10.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Country

10.3.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2026)

10.3.2 Turkey Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

10.3.4 UAE Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Bio Similars/Subsequent Entry Biologic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Bio Similars/Subsequent Entry Biologic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Region (2016-2021)

Table 5. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Region (2021-2026)

Table 6. Sun Pharma Corporate Information, Head Office, and Major Competitors

Table 7. Sun Pharma Major Business

Table 8. Sun Pharma Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 9. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Synthon Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Synthon Pharmaceuticals Major Business

Table 12. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 13. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors

Table 15. Teva Pharmaceutical Industries Major Business

Table 16. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 17. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. LG Life Sciences Corporate Information, Head Office, and Major Competitors

Table 19. LG Life Sciences Major Business

Table 20. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 21. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Celltrion Biocon Corporate Information, Head Office, and Major Competitors

Table 23. Celltrion Biocon Major Business

Table 24. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 25. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Hospira Corporate Information, Head Office, and Major Competitors

Table 27. Hospira Major Business

Table 28. Hospira Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 29. Hospira Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 33. Merck Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Biogen idec Corporate Information, Head Office, and Major Competitors

Table 35. Biogen idec Major Business

Table 36. Biogen idec Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 37. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Genentech (Roche) Corporate Information, Head Office, and Major Competitors

Table 39. Genentech (Roche) Major Business

Table 40. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 41. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Pfizer Corporate Information, Head Office, and Major Competitors

Table 43. Pfizer Major Business

Table 44. Pfizer Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 45. Pfizer Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Celltrion Corporate Information, Head Office, and Major Competitors

Table 47. Celltrion Major Business

Table 48. Celltrion Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 49. Celltrion Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Biocon Corporate Information, Head Office, and Major Competitors

Table 51. Biocon Major Business

Table 52. Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 53. Biocon Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Amgen Corporate Information, Head Office, and Major Competitors

Table 55. Amgen Major Business

Table 56. Amgen Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 57. Amgen Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Samsung Biologics Corporate Information, Head Office, and Major Competitors

Table 59. Samsung Biologics Major Business

Table 60. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 61. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Mylan Corporate Information, Head Office, and Major Competitors

Table 63. Mylan Major Business

Table 64. Mylan Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 65. Mylan Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Dr. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors

Table 67. Dr. Reddy's Laboratories Major Business

Table 68. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 69. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Stada Arzneimittel AG Corporate Information, Head Office, and Major Competitors

Table 71. Stada Arzneimittel AG Major Business

Table 72. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 73. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. AbbVie Corporate Information, Head Office, and Major Competitors

Table 75. AbbVie Major Business

Table 76. AbbVie Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 77. AbbVie Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors

Table 79. Sanofi-Aventis Major Business

Table 80. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 81. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 83. Johnson & Johnson Major Business

Table 84. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 85. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 87. Novo Nordisk Major Business

Table 88. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 89. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 91. Eli Lilly Major Business

Table 92. Eli Lilly Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 93. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Novartis Corporate Information, Head Office, and Major Competitors

Table 95. Novartis Major Business

Table 96. Novartis Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 97. Novartis Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. 3sbio Corporate Information, Head Office, and Major Competitors

Table 99. 3sbio Major Business

Table 100. 3sbio Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 101. 3sbio Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Biotech Corporate Information, Head Office, and Major Competitors

Table 103. Biotech Major Business

Table 104. Biotech Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 105. Biotech Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. Gelgen Corporate Information, Head Office, and Major Competitors

Table 107. Gelgen Major Business

Table 108. Gelgen Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 109. Gelgen Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Innovent Corporate Information, Head Office, and Major Competitors

Table 111. Innovent Major Business

Table 112. Innovent Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 113. Innovent Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Dong Bao Corporate Information, Head Office, and Major Competitors

Table 115. Dong Bao Major Business

Table 116. Dong Bao Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 117. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 118. Ganlee Corporate Information, Head Office, and Major Competitors

Table 119. Ganlee Major Business

Table 120. Ganlee Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 121. Ganlee Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 122. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Players (2019-2021)

Table 123. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2019-2021)

Table 124. Breakdown of Bio Similars/Subsequent Entry Biologic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 125. Bio Similars/Subsequent Entry Biologic Players Head Office, Products and Services Provided

Table 126. Bio Similars/Subsequent Entry Biologic Mergers & Acquisitions in the Past Five Years

Table 127. Bio Similars/Subsequent Entry Biologic New Entrants and Expansion Plans

Table 128. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Type (2016-2021)

Table 129. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2016-2021)

Table 130. Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2021-2026)

Table 131. Global Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021)

Table 132. Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2021-2026)

Table 133. North America Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2021) & (USD Million)

Table 134. North America Bio Similars/Subsequent Entry Biologic Revenue by Type (2021-2026) & (USD Million)

Table 135. North America Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021) & (USD Million)

Table 136. North America Bio Similars/Subsequent Entry Biologic Revenue by Application (2021-2026) & (USD Million)

Table 137. North America Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2021) & (USD Million)

Table 138. North America Bio Similars/Subsequent Entry Biologic Revenue by Country (2021-2026) & (USD Million)

Table 139. Europe Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2021) & (USD Million)

Table 140. Europe Bio Similars/Subsequent Entry Biologic Revenue by Type (2021-2026) & (USD Million)

Table 141. Europe Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021) & (USD Million)

Table 142. Europe Bio Similars/Subsequent Entry Biologic Revenue by Application (2021-2026) & (USD Million)

Table 143. Europe Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2021) & (USD Million)

Table 144. Europe Bio Similars/Subsequent Entry Biologic Revenue by Country (2021-2026) & (USD Million)

Table 145. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2021) & (USD Million)

Table 146. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Type (2021-2026) & (USD Million)

Table 147. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021) & (USD Million)

Table 148. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Application (2021-2026) & (USD Million)

Table 149. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Region (2016-2021) & (USD Million)

Table 150. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Region (2021-2026) & (USD Million)

Table 151. South America Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2021) & (USD Million)

Table 152. South America Bio Similars/Subsequent Entry Biologic Revenue by Type (2021-2026) & (USD Million)

Table 153. South America Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021) & (USD Million)

Table 154. South America Bio Similars/Subsequent Entry Biologic Revenue by Application (2021-2026) & (USD Million)

Table 155. South America Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2021) & (USD Million)

Table 156. South America Bio Similars/Subsequent Entry Biologic Revenue by Country (2021-2026) & (USD Million)

Table 157. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Type (2016-2021) & (USD Million)

Table 158. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Type (2021-2026) & (USD Million)

Table 159. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Application (2016-2021) & (USD Million)

Table 160. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Application (2021-2026) & (USD Million)

Table 161. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Country (2016-2021) & (USD Million)

Table 162. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Bio Similars/Subsequent Entry Biologic Picture

Figure 2. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type in 2020

Figure 3. Monoclonal Antibodies

Figure 4. Interferon

Figure 5. Erythropoietin

Figure 6. Insulin

Figure 7. Vaccines

Figure 8. Other

Figure 9. Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application in 2020

Figure 10. Tumor Picture

Figure 11. Diabetes Picture

Figure 12. Cardiovascular Picture

Figure 13. Hemophilia Picture

Figure 14. Other Picture

Figure 15. Global Bio Similars/Subsequent Entry Biologic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Bio Similars/Subsequent Entry Biologic Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Region (2016-2026)

Figure 18. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Region in 2020

Figure 19. North America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Bio Similars/Subsequent Entry Biologic Market Drivers

Figure 25. Bio Similars/Subsequent Entry Biologic Market Restraints

Figure 26. Bio Similars/Subsequent Entry Biologic Market Trends

Figure 27. Sun Pharma Recent Developments and Future Plans

Figure 28. Synthon Pharmaceuticals Recent Developments and Future Plans

Figure 29. Teva Pharmaceutical Industries Recent Developments and Future Plans

Figure 30. LG Life Sciences Recent Developments and Future Plans

Figure 31. Celltrion Biocon Recent Developments and Future Plans

Figure 32. Hospira Recent Developments and Future Plans

Figure 33. Merck Recent Developments and Future Plans

Figure 34. Biogen idec Recent Developments and Future Plans

Figure 35. Genentech (Roche) Recent Developments and Future Plans

Figure 36. Pfizer Recent Developments and Future Plans

Figure 37. Celltrion Recent Developments and Future Plans

Figure 38. Biocon Recent Developments and Future Plans

Figure 39. Amgen Recent Developments and Future Plans

Figure 40. Samsung Biologics Recent Developments and Future Plans

Figure 41. Mylan Recent Developments and Future Plans

Figure 42. Dr. Reddy's Laboratories Recent Developments and Future Plans

Figure 43. Stada Arzneimittel AG Recent Developments and Future Plans

Figure 44. AbbVie Recent Developments and Future Plans

Figure 45. Sanofi-Aventis Recent Developments and Future Plans

Figure 46. Johnson & Johnson Recent Developments and Future Plans

Figure 47. Novo Nordisk Recent Developments and Future Plans

Figure 48. Eli Lilly Recent Developments and Future Plans

Figure 49. Novartis Recent Developments and Future Plans

Figure 50. 3sbio Recent Developments and Future Plans

Figure 51. Biotech Recent Developments and Future Plans

Figure 52. Gelgen Recent Developments and Future Plans

Figure 53. Innovent Recent Developments and Future Plans

Figure 54. Dong Bao Recent Developments and Future Plans

Figure 55. Ganlee Recent Developments and Future Plans

Figure 56. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2020

Figure 57. Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 58. Global Top 3 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2020

Figure 59. Global Top 10 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2020

Figure 60. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 61. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type in 2020

Figure 62. Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2021-2026)

Figure 63. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application in 2020

Figure 64. Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2021-2026)

Figure 65. North America Bio Similars/Subsequent Entry Biologic Sales Market Share by Type (2016-2026)

Figure 66. North America Bio Similars/Subsequent Entry Biologic Sales Market Share by Application (2016-2026)

Figure 67. North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Country (2016-2026)

Figure 68. United States Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Europe Bio Similars/Subsequent Entry Biologic Sales Market Share by Type (2016-2026)

Figure 72. Europe Bio Similars/Subsequent Entry Biologic Sales Market Share by Application (2016-2026)

Figure 73. Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Country (2016-2026)

Figure 74. Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. United Kingdom Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Asia-Pacific Bio Similars/Subsequent Entry Biologic Sales Market Share by Type (2016-2026)

Figure 80. Asia-Pacific Bio Similars/Subsequent Entry Biologic Sales Market Share by Application (2016-2026)

Figure 81. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Region (2016-2026)

Figure 82. China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. South Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Australia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. South America Bio Similars/Subsequent Entry Biologic Sales Market Share by Type (2016-2026)

Figure 89. South America Bio Similars/Subsequent Entry Biologic Sales Market Share by Application (2016-2026)

Figure 90. South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Country (2016-2026)

Figure 91. Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 92. Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 93. Middle East and Africa Bio Similars/Subsequent Entry Biologic Sales Market Share by Type (2016-2026)

Figure 94. Middle East and Africa Bio Similars/Subsequent Entry Biologic Sales Market Share by Application (2016-2026)

Figure 95. Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Country (2016-2026)

Figure 96. Turkey Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 97. Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 98. UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 99. Methodology

Figure 100. Research Process and Data Source